|
|
News Breaks
|
November 19, 2009
|
| 08:09 EDT |  | CSII |
| theflyonthewall.com: | Cardiovascular Systems begins patient enrollment for CALCIUM 360° trial | | Cardiovascular Systems announces the first patient enrollment in its prospective, randomized CALCIUM 360° clinical trial. The CALCIUM 360° study will compare the effectiveness of treatment of peripheral arterial disease - or PAD - behind and below the knee using CSIs Diamondback 360 PAD System, a minimally invasive catheter for treating PAD anywhere in the leg, to treatment with balloon angioplasty. The study will enroll 50 patients and follow them for 12 months. :theflyonthewall.com |
|
|
News For CSII From The Last 14 Days Check below for free stories on CSII the last two weeks.
There are 3 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
February 8, 2012
|
| 06:46 EDT |  | CSII |
| theflyonthewall.com: | Cardiovascular Systems downgraded to Market Perform at William Blair | | William Blair downgraded Cardiovascular Systems to Market Perform from Outperform following the company's weaker than expected Q2 results. William Blair believes Cardiovascular Systems is having a difficult time increasing penetration and utilization by hospitals and office]based labs. :theflyonthewall.com |
|
|
February 7, 2012
|
| 16:32 EDT |  | CSII |
| | 16:32 EDT | | CSII |
| theflyonthewall.com: | Cardiovascular Systems reports Q2 EPS (23c) vs. consensus (20c) | | Reports Q2 revenue $19.7M vs. consensus $20.95M. :theflyonthewall.com |
|
|
|
|
|
Subscribe for More Information